From: The role of TBK1 in cancer pathogenesis and anticancer immunity
Compounds | Targets | Reference | Clinical Trial |
---|---|---|---|
Amlexanox (AMX) | TBK1/IKKε | NCT01842282; NCT01975935 | |
AZ13102909 (AZ909) | TBK1 | [223] | Â |
BAY-985 | TBK1/IKKε | [253] |  |
BX795 | TBK1/IKKε Aurora B NUAK1 PDK1 |  | |
Compound I | TBK1/IKKε | [244] |  |
Compound II | TBK1/IKKε |  | |
DMX-14 | TBK1/IKKε | [258] |  |
GSK8612 | TBK1 | [259] | Â |
MDK10496 | TBK1/IKKε | [260] |  |
MMB/CYT387/GS-0387 | TBK1/IKKε ACVR1 ALK2 JAK1/2 | NCT02101021; NCT02206763; NCT02258607; NCT04173494/MOMENTUM; NCT01969838/SIMPLIFY1; NCT02101268 | |
MPI-0485520 | TBK1/IKKε | [268] |  |
MRT67307 | TBK1/IKKε ULK1/2 | [99] |  |
MRT68601 | TBK1 | [255] | Â |
UNC6587/Cereblon-TBK1 PROTAC | TBK1 | [81] | Â |
15a | TBK1/IKKε Aurora A GSK3β Aurora A PDK1 | [269] |  |
200A | TBK1/IKKε | [270] |  |
3i/pVHL-TBK1 PROTAC | TBK1 | [271] | Â |